• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患者完全活动能力人群中低骨密度的预测因素和流行率。

Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis.

机构信息

Department of Neurology, University Hospital of North Norway, P.O. Box 33, 9038, Tromsø, Norway.

出版信息

J Neurol. 2010 Mar;257(3):410-8. doi: 10.1007/s00415-009-5337-6. Epub 2009 Oct 1.

DOI:10.1007/s00415-009-5337-6
PMID:19795152
Abstract

The implications of having multiple sclerosis (MS) for bone health are incompletely understood. The aim of this population-based study is to identify past and current exposures that are associated with bone mass in fully ambulatory persons with MS up to age 50 years and to determine the prevalence of low bone mineral density (BMD) in this group. We measured BMD (hips, lumbar spine, forearms), physical function, BMI, and serum 25(OH) vitamin D in 55 women and 25 men with MS. Patients provided information on demographic variables and medical history, as well as past and current vitamin D and calcium intake, physical activity, and lifestyle habits. In regression analyses, BMD levels were adjusted for age, sex, and BMI. At the femoral neck, strong associations were found for walking distance (beta = 0.152; P < 0.001) and age (beta = -0.004; P = 0.003), and less certain associations for male sex (beta = 0.055; P = 0.014) and 10-foot timed tandem walk (-0.008; P = 0.013). At the lumbar spine, walking distance (beta = 0.013; P = 0.006) and possibly physical activity growing up (beta = 0.035; P = 0.028) and male sex (beta = -0.057; P = 0.042), were associated with BMD. At the ultradistal radius, strength of grip (beta = 0.001; P = 0.002), and, less certainly, summer outdoor activities age 16-20 (beta = 0.021; P = 0.009), and age at MS onset (beta = 0.002; P = 0.036) were associated with BMD. Low BMD (z score < or = -2) was present in 19 out of 80 patients. This study shows that MS-related variables as well as past exposures differentially affect BMD at three clinically important skeletal sites. Low BMD is prevalent in these young patients. Bone health should receive attention in care for persons with MS.

摘要

多发性硬化症(MS)对骨骼健康的影响尚未完全阐明。本项基于人群的研究旨在确定与 50 岁以下完全活动的 MS 患者的骨量相关的过去和当前的暴露因素,并确定该组患者中低骨密度(BMD)的患病率。我们测量了 55 名女性和 25 名男性 MS 患者的 BMD(髋部、腰椎、前臂)、身体功能、BMI 和血清 25(OH)维生素 D。患者提供了人口统计学变量和病史、过去和当前的维生素 D 和钙摄入量、身体活动以及生活方式习惯的信息。在回归分析中,BMD 水平根据年龄、性别和 BMI 进行了调整。在股骨颈处,行走距离(β=0.152;P<0.001)和年龄(β=-0.004;P=0.003)与 BMD 呈强相关,而男性(β=0.055;P=0.014)和 10 英尺计时并足走(β=-0.008;P=0.013)与 BMD 的相关性不太确定。在腰椎处,行走距离(β=0.013;P=0.006)和可能的青少年时期身体活动(β=0.035;P=0.028)以及男性(β=-0.057;P=0.042)与 BMD 相关。在桡骨远端,握力(β=0.001;P=0.002)与 BMD 相关,而不太确定的是,16-20 岁时的夏季户外活动(β=0.021;P=0.009)和 MS 发病年龄(β=0.002;P=0.036)与 BMD 相关。80 名患者中有 19 名存在低 BMD(z 评分<或=-2)。本研究表明,MS 相关的变量以及过去的暴露因素对三个重要的骨骼部位的 BMD 有不同的影响。这些年轻患者中低 BMD 较为常见。MS 患者的骨骼健康应受到关注。

相似文献

1
Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis.多发性硬化症患者完全活动能力人群中低骨密度的预测因素和流行率。
J Neurol. 2010 Mar;257(3):410-8. doi: 10.1007/s00415-009-5337-6. Epub 2009 Oct 1.
2
Prevalence and risk factors of low bone mineral density in patients with multiple sclerosis.多发性硬化症患者低骨密度的患病率及危险因素
Acta Clin Belg. 2015 Jun;70(3):188-92. doi: 10.1179/2295333715Y.0000000002.
3
Risk of bone loss in men with multiple sclerosis.患有多发性硬化症的男性出现骨质流失的风险。
Mult Scler. 2004 Apr;10(2):170-5. doi: 10.1191/1352458504ms993oa.
4
Determinants of low bone mineral density in people with multiple sclerosis: Role of physical activity.多发性硬化症患者骨密度降低的决定因素:体力活动的作用。
Mult Scler Relat Disord. 2020 Feb;38:101864. doi: 10.1016/j.msard.2019.101864. Epub 2019 Nov 23.
5
Lack of association between vitamin D levels and bone mineral density in patients with multiple sclerosis.多发性硬化症患者维生素 D 水平与骨密度之间缺乏关联。
J Neurol Sci. 2012 Feb 15;313(1-2):137-41. doi: 10.1016/j.jns.2011.09.002. Epub 2011 Oct 10.
6
Strong familial association of bone mineral density between parents and offspring: KNHANES 2008-2011.父母与子女之间骨密度的强烈家族关联性:KNHANES 2008-2011。
Osteoporos Int. 2017 Mar;28(3):955-964. doi: 10.1007/s00198-016-3806-1. Epub 2016 Oct 17.
7
Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn.布鲁克林一个极端正统犹太社区青少年的脊柱骨密度降低。
Pediatrics. 2001 May;107(5):E79. doi: 10.1542/peds.107.5.e79.
8
Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men.年龄、体重指数、当前吸烟史以及血清胰岛素样生长因子-I水平与中年韩国男性的骨矿物质密度相关。
J Bone Miner Metab. 2004;22(4):392-8. doi: 10.1007/s00774-003-0500-0.
9
Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort.峰值骨量的决定因素:加拿大年轻女性队列的临床与遗传分析
J Bone Miner Res. 1999 Apr;14(4):633-43. doi: 10.1359/jbmr.1999.14.4.633.
10
Influence of age and gender on associations of body mass index with bone mineral density, bone turnover markers and circulating calcium-regulating and bone-active sex hormones.年龄和性别对体重指数与骨密度、骨转换标志物以及循环钙调节和骨活性性激素的关联的影响。
Bone. 2011 Oct;49(4):824-9. doi: 10.1016/j.bone.2011.06.003. Epub 2011 Jun 12.

引用本文的文献

1
Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)D, but No Difference in Ratio of 25(OH)D/24,25(OH)D and FGF23 Concentrations.多发性硬化症患者的生物可利用 25(OH)D 和 1,25(OH)D 水平较低,但 25(OH)D/24,25(OH)D 比值和 FGF23 浓度无差异。
Nutrients. 2019 Nov 15;11(11):2774. doi: 10.3390/nu11112774.
2
Assessment of Biochemical and Densitometric Markers of Calcium-Phosphate Metabolism in the Groups of Patients with Multiple Sclerosis Selected due to the Serum Level of Vitamin D.根据血清维生素 D 水平选择的多发性硬化症患者组中钙磷代谢的生化和密度计量标志物评估。
Biomed Res Int. 2018 Aug 23;2018:9329123. doi: 10.1155/2018/9329123. eCollection 2018.
3

本文引用的文献

1
Osteoporosis risk in premenopausal women.绝经前女性的骨质疏松风险
Pharmacotherapy. 2009 Mar;29(3):305-17. doi: 10.1592/phco.29.3.305.
2
Comment on Shuhaibar et al.: Favourable effect of immunomodulator therapy on bone mineral density in multiple sclerosis.关于舒海巴尔等人的评论:免疫调节剂疗法对多发性硬化症骨密度的有利影响。
Ir J Med Sci. 2009 Jun;178(2):235-6; author reply 237-8. doi: 10.1007/s11845-009-0275-y. Epub 2009 Jan 31.
3
Bone health in ambulatory individuals with multiple sclerosis: impact of physical activity, glucocorticoid use, and body composition.
High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.
高剂量补充维生素D对多发性硬化症患者的生化骨标志物无影响——一项随机对照试验
BMC Neurol. 2017 Apr 4;17(1):67. doi: 10.1186/s12883-017-0851-0.
4
Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.神经疾病患者代谢性骨病的危险因素、流行病学及治疗策略
Curr Osteoporos Rep. 2016 Oct;14(5):199-210. doi: 10.1007/s11914-016-0320-5.
5
Lack of Association between Pulse Steroid Therapy and Bone Mineral Density in Patients with Multiple Sclerosis.多发性硬化症患者脉冲类固醇治疗与骨矿物质密度之间缺乏关联。
Mult Scler Int. 2016;2016:5794910. doi: 10.1155/2016/5794910. Epub 2016 Feb 4.
6
Osteoporosis and multiple sclerosis: risk factors, pathophysiology, and therapeutic interventions.骨质疏松症与多发性硬化症:危险因素、病理生理学及治疗干预措施
CNS Drugs. 2014 Aug;28(8):731-42. doi: 10.1007/s40263-014-0173-3.
7
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.维生素 D 不足在多发性硬化发病机制中的作用。
Ther Adv Neurol Disord. 2013 Mar;6(2):81-116. doi: 10.1177/1756285612473513.
8
Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study.维生素 D 受体 Bsm1 多态性、钙代谢与多发性硬化症患者骨密度:一项初步研究。
Neurol Sci. 2013 Aug;34(8):1433-9. doi: 10.1007/s10072-012-1259-7. Epub 2012 Dec 5.
9
Effect of high-dose vitamin D3 intake on ambulation, muscular pain and bone mineral density in a woman with multiple sclerosis: a 10-year longitudinal case report.高剂量维生素D3摄入对一名多发性硬化症女性的行走能力、肌肉疼痛和骨密度的影响:一项为期10年的纵向病例报告。
Int J Mol Sci. 2012 Oct 19;13(10):13461-83. doi: 10.3390/ijms131013461.
10
Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study.早期多发性硬化症和普遍骨量不足患者的骨转换和代谢:一项基于人群的病例对照研究。
PLoS One. 2012;7(9):e45703. doi: 10.1371/journal.pone.0045703. Epub 2012 Sep 19.
多发性硬化症门诊患者的骨骼健康:身体活动、糖皮质激素使用及身体成分的影响
J Rehabil Res Dev. 2008;45(6):851-61. doi: 10.1682/jrrd.2007.10.0159.
4
The role of osteopontin: a shared pathway in the pathogenesis of multiple sclerosis and osteoporosis?骨桥蛋白的作用:多发性硬化症和骨质疏松症发病机制中的共同途径?
J Neurol Sci. 2009 Jan 15;276(1-2):41-4. doi: 10.1016/j.jns.2008.08.031. Epub 2008 Oct 9.
5
Vitamin D: a candidate for the environmental effect in multiple sclerosis - observations from Norway.维生素D:多发性硬化症环境影响的一个候选因素——来自挪威的观察结果
Neuroepidemiology. 2008;30(3):140-6. doi: 10.1159/000122330. Epub 2008 Apr 2.
6
Vitamin D deficiency.维生素D缺乏症
N Engl J Med. 2007 Jul 19;357(3):266-81. doi: 10.1056/NEJMra070553.
7
A longitudinal study of infant feeding and obesity throughout life course.一项关于婴儿喂养与一生肥胖情况的纵向研究。
Int J Obes (Lond). 2007 Jul;31(7):1078-85. doi: 10.1038/sj.ijo.0803622. Epub 2007 Apr 24.
8
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia.澳大利亚塔斯马尼亚州多发性硬化症患者与社区对照人群的维生素D水平
J Neurol. 2007 May;254(5):581-90. doi: 10.1007/s00415-006-0315-8. Epub 2007 Apr 11.
9
Comparison of diet measures from a food-frequency questionnaire with measures from repeated 24-hour dietary recalls. The Norwegian Women and Cancer Study.食物频率问卷中的饮食测量方法与多次24小时饮食回顾法测量结果的比较。挪威女性与癌症研究。
Public Health Nutr. 2007 Oct;10(10):1094-103. doi: 10.1017/S1368980007702872. Epub 2007 Mar 15.
10
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.骨免疫学:免疫与骨骼系统之间的共同机制及相互作用
Nat Rev Immunol. 2007 Apr;7(4):292-304. doi: 10.1038/nri2062.